Nonmyeloablative allogeneic stem cell transplantation (NST) after truly nonmyeloablative and reduced intensity conditioning regimens

被引:25
|
作者
Banna, GL [1 ]
Aversa, S [1 ]
Sileni, VC [1 ]
Favaretto, A [1 ]
Ghiotto, C [1 ]
Monfardini, S [1 ]
机构
[1] Univ Hosp Padova, Med Oncol Unit, I-35128 Padua, Italy
关键词
nonmyeloablative; reduced intensity conditioning; mini-allograft;
D O I
10.1016/j.critrevonc.2004.05.008
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Nonmyeloablative allogeneic stem cell transplantation (NST) has been explored to overcome transplant-related mortality (TRM). From the review of 39 published reports, 50% of the 1484 treated patients had NSTs with truly nonmyeloablative conditioning (NMC) and 417 patients (29%) received an unrelated donor transplant (UDT). Median age was 49 years (range 17-59). A median dose of 4.74 x 10(6) CD34+ per kg (range 1.7-7.5) was administered. Hematological recovery was rapid with all the regimens used. Sustained engraftment was obtained in 1267/1355 assessable patients (94%, range 67-100%). Complete donor chimerism was observed in 707/948 assessable patients (75%, range 22-100%). Both were higher after reduced intensity conditioning (RIC) than after NMC regimens. Reject was more frequent after UDT and NMC regimens. Grades Il-IV and III-IV acute graft versus host disease (GVHD) occurred in 580/1400 (41%; range 7-72%) and 188/1093 (17%; range 0-29%) assessable patients, respectively; grades II-IV and III-IV acute GVHD were more frequent after UDT and RIC regimens, respectively. Chronic GVHD occurred in 407/1046 assessable patients (39%; range 0-79%) and extensive chronic GVHD in 166/835 patients (20%; range 0-69%); they were more frequent after RIC regimens and less frequent after UDT. Transplant-related mortality (TRM) rate of 20.6%, without differences between RIC and NMC regimens, was observed; TRM was higher with UDTs. The most frequent causes of TRM were acute or chronic GVHD after RIC regimens and infections after NMC regimens and UDTs. Indolent lymphoid malignancies and some solid tumors appear sensitive to the graft versus malignancy (GVM) effect. NSTs could guarantee relatively low TRM and toxicity in patients not eligible for conventional allogeneic transplantation and could represent a platform for successive specific immunotherapy. (C) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:171 / 189
页数:19
相关论文
共 50 条
  • [1] NONMYELOABLATIVE AND REDUCED INTENSITY CONDITIONING IN ALLOGENEIC STEM CELL TRANSPLANTATION FOR MYELOFIBROSIS
    Malone, A. K.
    Scigliano, E.
    Grosskreutz, C.
    Osman, K.
    Isola, L.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (02) : S285 - S285
  • [2] Allogeneic stem cell transplantation for autoimmune diseases: nonmyeloablative conditioning regimens
    Oyama, Y
    Traynor, AE
    Barr, W
    Burt, RK
    [J]. BONE MARROW TRANSPLANTATION, 2003, 32 (Suppl 1) : S81 - S83
  • [3] Allogeneic stem cell transplantation for autoimmune diseases: nonmyeloablative conditioning regimens
    Y Oyama
    A E Traynor
    W Barr
    R K Burt
    [J]. Bone Marrow Transplantation, 2003, 32 : S81 - S83
  • [4] A comparison of nonmyeloablative and reduced-intensity conditioning for allogeneic stem-cell transplantation
    Le Blanc, K
    Remberger, M
    Uzunel, M
    Mansson, J
    Barkholt, L
    Ringdén, O
    [J]. TRANSPLANTATION, 2004, 78 (07) : 1014 - 1020
  • [5] Nonmyeloablative and Reduced-Intensity Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation A Clinical Review
    Pollack, Seth M.
    O'Connor, Thomas P., Jr.
    Hashash, Jana
    Tabbara, Imad A.
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2009, 32 (06): : 618 - 628
  • [6] Reduced intensity versus truly nonmyeloablative conditioning for stem-cell transplant recipients
    Slavin, S
    [J]. TRANSPLANTATION, 2004, 78 (07) : 964 - 965
  • [7] Transfusions after nonmyeloablative or reduced-intensity conditioning regimens
    Baron F.
    Vanstraelen G.
    Beguin Y.
    [J]. Leukemia, 2006, 20 (12) : 2081 - 2086
  • [8] Immune reconstitution following allogeneic nonmyeloablative stem cell transplantation (NST)
    Busca, A
    Falda, M
    Genetta, C
    Lovisone, E
    Aliberti, S
    Francisci, T
    Omede, P
    Rege Cambrin, G
    Barbul, A
    Gallo, E
    Rossi, G
    Locatelli, F
    [J]. BONE MARROW TRANSPLANTATION, 2002, 29 : S155 - S155
  • [9] Treatment of hematological malignancies with allogeneic nonmyeloablative stem cell transplantation: conditioning regimens with fludarabine
    Carella, AM
    [J]. HEMATOLOGY JOURNAL, 2004, 5 : S68 - S75
  • [10] Infections after allogeneic hematopoietic stem cell transplantation with a nonmyeloablative conditioning regimen
    Frère, P
    Baron, F
    Bonnet, C
    Hafraoui, K
    Pereira, M
    Willems, E
    Fillet, G
    Beguin, Y
    [J]. BONE MARROW TRANSPLANTATION, 2006, 37 (04) : 411 - 418